TriMark Publications Announces Release of Its Clinical Laboratory Testing Reports

TriMark Publications (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Clinical Laboratory Testing reports Volumes 1 and 2.

New York, NY (PRWEB) May 4, 2007 -- TriMark Publications (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Clinical Laboratory Testing reports Volumes 1 and 2. The first report entitled "Clinical Laboratory Testing Volume 1: Reagents and Instruments" examines the specific segments of the global clinical laboratory instrumentation and reagent market. The second report entitled "Clinical Laboratory Testing Volume 2: Business Strategies" focuses on those companies that are actively developing and marketing laboratory data for the clinical setting, including hospitals, independent labs, physicians offices and miscellaneous clinics.

Clinical laboratory testing is one of the most important sectors of medical care. By all accounts, it is very mature, large and diverse. The term clinical laboratory testing usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids, such as blood, serum, plasma or urine. Both reports answer the following questions for their respective focus:

• Which companies are the key players?

• What are the opportunities in clinical laboratory instrumentation and reagent markets?

• What is happening with the information revolution in lab instruments?

• What are the developing trends?

• Where are the new market growth areas?

• What are the most favored lab analysis technology platforms?

• Where is the laboratory analyzer instrument technology taking us?

• How is immunological technology blending with more established laboratory procedures?

• What are the business trends in the IVD industry?

Each company is discussed in depth with a section on the history of the company, product lines, business and marketing analysis, and a subjective commentary of the position of the company in its market. The unique benefits of the reports are:

• In-depth analyses of the major sectors of the clinical laboratory instrumentation and reagent sectors, their size, growth rates and major drivers.

• Presentations of some of the emerging technology platforms, elucidating the potential areas that could gain traction in this market.

• Analyses of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.

• Examinations of new technology platforms in the U.S., Japan and Europe that seek to dominate this mature market, and to identify lead positions and potential future growth areas.

Reasons to Buy TriMark Content

• Content is updated regularly in accordance with changes in the industries our reports cover.

• Content is specifically designed to help individuals who work in the industries the content covers remain competitive in the marketplace.

• Content contains detailed sales data, market share information and emerging trends, all of which impact the sectors biotechnology, healthcare, pharmaceutical and medical devices companies operate in.

• Your competitors are buying TriMark content.

About TriMark Publications, LLC

Based in New York City, TriMark Publications is a global leader in the biotechnology, healthcare and life sciences publishing. TriMarks market research reports include the following:

• Avian Influenza: The Threatening Pandemic

• Bioinformatics Markets

• Blood Gas Instrumentation Data Processing

• Blood Glucose Testing and Diabetes Management

• Cancer Diagnostic Testing World Markets

• Cancer Therapeutics Markets

• Cardiac Marker Diagnostic Testing Markets

• Cardiac Rhythm Management Devices World Markets

• Cell Therapy Market

• Clinical Chemistry Analyzers

• Clinical Immunoanalyzer Markets

• Clinical Laboratory Testing Volume 1: Reagents and Instruments

• Clinical Laboratory Testing Volume 2: Business Strategies

• Cytology and HPV Testing World Markets

• Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets

• Disposable Medical Supplies Markets

• Disposable Syringe Markets

• DNA Sequencing and PCR Markets

• Drug Discovery Tools For High Content And Secondary Analysis

• Gene Expression Reagents Markets

• Genomics World Markets

• Hematology Analyzer Instrumentation and Reagent Markets

• High-Growth Diagnostic Tests Markets

• Indian Pharmaceutical Industry

• Key Diagnostic Testing Markets

• Mammography World Markets

• Medical Imaging Markets

• Microarray Markets

• Microscopy Markets

• Molecular Diagnostics Markets

• Multi-Parameter Patient Monitor Markets

• Nuclear Cardiology Markets

• Nutraceuticals and Dietary Supplements Markets

• Over-the-Counter Diagnostic Products World Markets

• Personalized Medicine

• Pharmacogenomic Testing Markets

• Point of Care Diagnostic Testing Sector Trends

• Point of Care Diagnostic Testing World Markets

• RNA Interference Markets

• Stem Cell Markets

• Veterinary Health Markets

• Womens Health Diagnostic Tests

For more information, please visit http://www.trimarkpublications.com.

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Contact:

Media Relations

TriMark Publications, LLC

212.265.9877

www.trimarkpublications.com

# # #